Synairgen Plc (SNG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,554 | 10,516 | 15,926 | 33,827 | 74,976 |
| Marketable Securities | N/A | 1,500 | 3,750 | N/A | N/A |
| Inventories | N/A | N/A | N/A | 0 | 41 |
| Other current assets | 3,067 | 2,077 | 3,723 | 10,585 | 13,143 |
| TOTAL | $7,621 | $14,093 | $23,399 | $44,412 | $88,160 |
| Non-Current Assets | |||||
| PPE Net | 101 | 26 | 86 | 173 | 344 |
| Intangibles | 100 | 102 | 44 | 53 | 44 |
| TOTAL | $201 | $128 | $130 | $226 | $388 |
| Total Assets | $7,822 | $14,221 | $23,529 | $44,638 | $88,548 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 764 | 592 | 548 | 4,157 | 1,541 |
| TOTAL | $1,544 | $1,564 | $3,254 | $7,638 | $3,407 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,544 | $1,564 | $3,254 | $7,638 | $3,407 |
| Shareholders' Equity | |||||
| Common Shares | 2,027 | 2,014 | 2,014 | 2,013 | 1,999 |
| Retained earnings | -121,477 | -115,085 | -107,467 | -90,741 | -42,586 |
| Other shareholders' equity | 483 | 483 | 483 | 483 | 483 |
| TOTAL | $6,278 | $12,657 | $20,275 | $37,000 | $85,141 |
| Total Liabilities And Equity | $7,822 | $14,221 | $23,529 | $44,638 | $88,548 |